UCB Ventures

UCB Ventures is a strategic corporate venture fund set up in 2017 by the pharmaceutical group UCB. It has no fixed end date and makes long-term investments in early-stage companies.

Its aim is to find new insights and technologies that could change the lives of people with severe diseases. It works closely with entrepreneurs and describes itself as fast and agile but careful in its approach.

Products and services

• Early-stage investment: funding for young companies in the US and Europe.
• Novel therapies: backing for new treatment types and platforms addressing new biology.
• Digital health: digital tools for patients, including patient engagement solutions.
• Support for founders: close work with entrepreneurs over the long term.

Who it works with

Start-ups working on next-generation cell and gene therapy, tissue repair, RNA-targeted medicines and tools that engage patients. It also looks at areas next to or beyond UCB's current therapeutic focus.

Key facts

• Founded: 2017
• Structure: evergreen corporate venture fund
• Regions: US and Europe